|
Volumn 256, Issue SUPPL. 1, 2009, Pages 42-46
|
Clinical experience with high-dose idebenone in Friedreich ataxia
a b c |
Author keywords
Cardiomyopathy; Clinical trials; FARS; Friedreich ataxia; ICARS; Idebenone; Neurologic; Oxidative stress; Rare disorders
|
Indexed keywords
IDEBENONE;
PLACEBO;
AGE DISTRIBUTION;
ARTICLE;
BLOOD CHEMISTRY;
CLINICAL TRIAL;
DIARRHEA;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG DOSE ESCALATION;
DRUG DOSE INCREASE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPEPSIA;
ELECTROCARDIOGRAM;
FRIEDREICH ATAXIA;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
LOOSE FECES;
LOW DRUG DOSE;
NAUSEA;
NONHUMAN;
PRIORITY JOURNAL;
SIDE EFFECT;
VITAL SIGN;
VOMITING;
ANTIOXIDANTS;
CARDIOMYOPATHIES;
CLINICAL PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FRIEDREICH ATAXIA;
HUMANS;
NERVOUS SYSTEM DISEASES;
UBIQUINONE;
|
EID: 62549107066
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-1008-x Document Type: Article |
Times cited : (40)
|
References (19)
|